Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Oct;12(4):2782-2788.
doi: 10.3892/ol.2016.5012. Epub 2016 Aug 16.

Differential expression of viral agents in lymphoma tissues of patients with ABC diffuse large B-cell lymphoma from high and low endemic infectious disease regions

Affiliations

Differential expression of viral agents in lymphoma tissues of patients with ABC diffuse large B-cell lymphoma from high and low endemic infectious disease regions

Therese Högfeldt et al. Oncol Lett. 2016 Oct.

Abstract

Diffuse large B-cell lymphoma (DLBCL), the most common type of non-Hodgkin's lymphoma (NHL) in adults, accounts for approximately 30-40% of newly diagnosed lymphomas worldwide. Environmental factors, such as viruses and bacteria, may contribute to cancer development through chronic inflammation and the integration of oncogenes, and have previously been indicated in cervical cancer, hepatocellular carcinoma, gastric cancer and lymphoproliferative disorders. In the present study, the presence of microbial agents was analyzed in the lymphoma tissue of patients with activated B-cell like (ABC) DLBCL. The present study compared two groups of patients from geographically varied regions that possess a difference in the prevalence of viral and other microbial agents. The patient populations were from Sweden (a low endemic infectious disease region) and Egypt (a high endemic infectious disease region). A differential expression of several viruses in lymphoma tissues was noted when comparing Swedish and Egyptian patients. JC polyomavirus (JCV) was detected in Swedish and Egyptian patients and, uniquely, the complete hepatitis B virus (HBV) genome was detected only in Egyptian lymphoma patients. None of these viruses were detected in control lymph tissues from Sweden or Egypt. In total, 38% of the Egyptian patients were found to have HBV surface antigens (HBsAgs) in their serum; however, HBsAgs were not found in any of the Swedish patients. The percentage of serum HBsAgs in Egyptian patients with ABC DLBCL was significantly increased compared with the general Egyptian population (P<0.05). The present study may support a notion that viral agents, including JCV and HBV, may be involved in the tumorigenesis of DLBCL in regions of high infectious disease.

Keywords: gene array; hepatitis B virus; lymphoma and Hodgkin disease; molecular genetics; virus.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Bar graph showing detected viruses from the microbial detection array. Log-odd scores are indicated on the y-axis. Red bars indicate Egyptian patients, blue bars indicate Swedish patients, purple bars indicate Egyptian control samples and green bars indicate Swedish control samples. Each bar indicates the detection of a virus, including the complete genome, strain or isolate. Strains and isolate numbers are indicated. Eg, Egyptian; Swe, Swedish.
Figure 2.
Figure 2.
Bar graph summarizing log-odd scores for each patient or control group. Statistical analysis (Student's t-test) was performed and indicates statistical difference between the groups. No significant difference was shown between the controls sample groups. EG, Egyptian; SWE, swedish; C, control; Pat, patient.
Figure 3.
Figure 3.
Box plot showing relative expression of (A) STAT3 and (B) miRNA in EG (+HBV) and EG (−HBV) patients and SV (−HBV) patients. Statistical analysis (analysis of variance) shows a significant difference between SV and EG patients. There were no statistical differences between EG (+HBV) and EG (−HBV) patients. EG, Egyptian, SV, Swedish; HBV, hepatitis B virus; STAT3, signal transducers and activators of transcription 3; miRNA, micro RNA.

Similar articles

Cited by

References

    1. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma, corp-author. The Non-Hodgkin's Lymphoma Classification Project. Blood. 1997;89:3909–3918. - PubMed
    1. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 2000;403:503–511. doi: 10.1038/35000501. - DOI - PubMed
    1. Rosenwald A, Wright G, Chan WC, Connors JM, Campo E, Fisher RI, Gascoyne RD, Muller-Hermelink HK, Smeland EB, Giltnane JM, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med. 2002;346:1937–1947. doi: 10.1056/NEJMoa012914. - DOI - PubMed
    1. Wright G, Tan B, Rosenwald A, Hurt EH, Wiestner A, Staudt LM. A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma. Proc Natl Acad Sci USA. 2003;100:9991–9996. doi: 10.1073/pnas.1732008100. - DOI - PMC - PubMed
    1. Liu YH, Xu FP, Zhuang HG, Lai KC, Xie D, Luo DL, Li L, Luo XL, Xu J, Zhang MH, et al. Clinicopathologic significance of immunophenotypic profiles related to germinal center and activation B-cell differentiation in diffuse large B-cell lymphoma from Chinese patients. Hum Pathol. 2008;39:875–884. doi: 10.1016/j.humpath.2007.10.013. - DOI - PubMed

LinkOut - more resources